651 results on '"Jørgensen, Erik"'
Search Results
52. Markov Limid processes for representing and solving renewal problems
53. Instent neointimal hyperplasia after percutaneous intervention for ST-elevation myocardial infarction and treatment with granulocyte-colony stimulating factor. Results from the stem cells in myocardial infarction (STEMMI) trial
54. Detection of neuron membranes in electron microscopy images using a serial neural network architecture
55. Timing of granulocyte-colony stimulating factor treatment after acute myocardial infarction and recovery of left ventricular function: Results from the STEMMI trial
56. ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance
57. Grid Tripping and Re-connection: Full-scale Experimental Validation of a Dynamic Wind Turbine Model
58. Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)
59. Feasibility and Safety of Prehospital Administration of Bivalirudin in Patients With ST-Elevation Myocardial Infarction
60. Monte Carlo characterization of high atomic number inorganic scintillators for in vivo dosimetry in 192Ir brachytherapy.
61. 3D dose reconstruction based on in vivo dosimetry for determining the dosimetric impact of geometric variations in high-dose-rate prostate brachytherapy.
62. Search and rescue helicopter-assisted transfer of ST-elevation myocardial infarction patients from an island in the Baltic Sea: results from over 100 rescue missions
63. Hypercoagulation Assessed by Thromboelastography is Neither Related to Infarct Size nor to Clinical Outcome After Primary Percutaneous Coronary Intervention
64. Clinical Approaches to Assess Neurological Outcomes of Cardiopulmonary Arrest in Unconscious Adults
65. Embedding a state space model into a Markov decision process
66. Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions: 3-Year Results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) Trial
67. Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary Intervention: The Drug Elution and Distal Protection in ST-Elevation Myocardial Infarction (DEDICATION) Trial
68. Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells
69. Impact of Acute Hyperglycemia on Myocardial Infarct Size, Area at Risk, and Salvage in Patients With STEMI and the Association With Exenatide Treatment: Results From a Randomized Study
70. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study
71. Eutrophication and agriculture in Denmark: 20 years of experience and prospects for the future
72. Demonstration of Requirements for Life Extension of Wind Turbines Beyond Their Design Life
73. Circulating angiogenic cytokines and stem cells in patients with severe chronic ischemic heart disease — Indicators of myocardial ischemic burden?
74. Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging
75. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study
76. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study
77. Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction
78. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)
79. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT)
80. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) Trial
81. Multi‐level hierarchic Markov processes as a framework for herd management support
82. No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses
83. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
84. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design
85. Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction
86. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events
87. Influence of distance from home to invasive centre on invasive treatment after acute coronary syndrome: a nationwide study of 24 910 patients
88. Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
89. Diagnosing diagnostic tests: evaluating the assumptions underlying the estimation of sensitivity and specificity in the absence of a gold standard
90. Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease
91. Exploring the Cost-Benefit of Vaccines for Infectious Diseases in Slaughter Pig Production
92. A high‐Z inorganic scintillator–based detector for time‐resolved in vivo dosimetry during brachytherapy.
93. Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route
94. 7,528 Patients Treated with PCI – A Scandinavian Real-Life Scenario
95. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease:A DANAMI-3–PRIMULTI Cardiac Magnetic Resonance Substudy
96. Fischer-Tropsch Synthesis: Conversion of Bio-Syngas to Hydrocarbons
97. Gastric antrectomy with selective gastric vagotomy does not influence gallbladder motility during interdigestive and postprandial periods
98. Stent treatment of coronary artery bifurcation lesions
99. Myocardial regeneration induced by granulocyte-colony-stimulating factor mobilization of stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical stem cell therapy?
100. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.